Literature DB >> 7904747

Correlation between the presence of a self-splicing intron in the 25S rDNA of C.albicans and strains susceptibility to 5-fluorocytosine.

S Mercure1, S Montplaisir, G Lemay.   

Abstract

Candida albicans presents a well characterized EcoRI RFLP pattern of intensely staining bands. One of these bands, the dimorphic 3.7/4.2 kbp fragment shown to originate from the ribosomal RNA-encoding regions (rDNA), has been used by several investigators to subdivide C. albicans strains in two distinct subtypes. In the present manuscript, we report that an epidemiological study of 120 C.albicans strains revealed a significant correlation between these subtypes and susceptibility to 5-fluorocytosine, an antifungal agent extensively used for biotyping C.albicans. The 4.2 kbp strains being generally more susceptible than their counterparts to this agent and one of its metabolic by-product, 5-fluorouracil. A 379 nucleotides insertion in the 25S rRNA-encoding gene of 4.2 kbp type strains was shown to be responsible for the 3.7/4.2 size difference. This intervening sequence is typical of a group I intron by its site of insertion, its predicted secondary structure, and its self-splicing capability. Assuming there is a genuine causal relationship between presence of the intron and resistance to 5-fluorocytosine, one possible mechanism suggests that inhibition of self-splicing by the insertion of 5-fluorouracil residues in the 25S rRNA precursor might be responsible for the higher susceptibility of 4.2 kbp type strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904747      PMCID: PMC310489          DOI: 10.1093/nar/21.25.6020

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  A compilation of large subunit (23S- and 23S-like) ribosomal RNA structures.

Authors:  R R Gutell; M N Schnare; M W Gray
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Numerous group I introns with variable distributions in the ribosomal DNA of a lichen fungus.

Authors:  P T DePriest; M D Been
Journal:  J Mol Biol       Date:  1992-11-20       Impact factor: 5.469

3.  Sequence and variability of the 5.8S and 26S rRNA genes of Pneumocystis carinii.

Authors:  Y Liu; M Rocourt; S Pan; C Liu; M J Leibowitz
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

Review 4.  Ribosomal RNA: a key to phylogeny.

Authors:  G J Olsen; C R Woese
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

5.  Complete nucleotide sequence of Candida albicans 5.8S rRNA coding gene and flanking internal transcribed spacers.

Authors:  S Mercure; N Rougeau; S Montplaisir; G Lemay
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

6.  Interest of biotyping Candida albicans in chronic vulvovaginitis.

Authors:  S Poirier; P Auger; J Joly; M Steben
Journal:  Mycoses       Date:  1990-01       Impact factor: 4.377

7.  Self-splicing of a mitochondrial group I intron from the cytochrome b gene of the ascomycete Podospora anserina.

Authors:  U Schmidt; E Budde; U Stahl
Journal:  Mol Gen Genet       Date:  1992-05

8.  Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.

Authors:  F C Odds
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Structure and evolution of myxomycete nuclear group I introns: a model for horizontal transfer by intron homing.

Authors:  S Johansen; T Johansen; F Haugli
Journal:  Curr Genet       Date:  1992-10       Impact factor: 3.886

10.  Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype.

Authors:  D A Stevens; F C Odds; S Scherer
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr
View more
  25 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  In vitro suicide inhibition of self-splicing of a group I intron from Pneumocystis carinii by an N3' --> P5' phosphoramidate hexanucleotide.

Authors:  S M Testa; S M Gryaznov; D H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Folding of the group I intron ribozyme from the 26S rRNA gene of Candida albicans.

Authors:  Y Zhang; M J Leibowitz
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

4.  Molecular epidemiology of Candida.

Authors:  David A Stevens
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Group I intron renders differential susceptibility of Candida albicans to Bleomycin.

Authors:  Prathiba Jayaguru; Malathi Raghunathan
Journal:  Mol Biol Rep       Date:  2006-11-07       Impact factor: 2.316

6.  Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

Authors:  C P Girish Kumar; Ahmed Medhat Hanafy; Masakazu Katsu; Yuzuru Mikami; Thangam Menon
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

7.  Three different group I introns in the nuclear large subunit ribosomal DNA of the amoeboflagellate Naegleria.

Authors:  J F De Jonckheere; S Brown
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

8.  Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing.

Authors:  Jessica L Childs; Matthew D Disney; Douglas H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

9.  Molecular analysis of Candida albicans isolates from clinical specimens.

Authors:  Melahat Gurbuz; Ilknur Kaleli
Journal:  Mycopathologia       Date:  2009-12-10       Impact factor: 2.574

10.  Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles.

Authors:  A Lischewski; M Ruhnke; I Tennagen; G Schönian; J Morschhäuser; J Hacker
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.